Fly News Breaks for January 30, 2020
Jan 30, 2020 | 09:24 EDT
Barrington analyst Michael Petusky raised his price target for Varian Medical Systems to $160 from $152 following the company's "solid" Q1 results. Order momentum in oncology remained "very solid" at 8% growth in dollars and 9% in constant currency, Petusky tells investors in a post-earnings research note. The analyst maintains an Outperform rating on Varian Medical shares.
News For VAR From the Last 2 Days
There are no results for your query VAR